Further, Tregs express EGFR in inflamed tumor microenvironments, and the mast cell‐derived epidermal growth factor‐like amphiregulin enhances Treg immunosuppressive effects, a phenomenon inhibited by EGFR–TKIs.2 Here, EGFR is linked to neoplasm.